Update: 23.08.2022
Last week: 32 week 2022 (08.08.2022 - 14.08.2022)
Last full month: July 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 87 210 | 19.2% | 3.8% | 0.2 | 17 314 040 | 18.5% | 3.7% | 0.2 | 14.2% |
| MoM | 467 964 | -5.9% | 6.2% | 0.9 | 91 081 370 | -7.9% | 5.7% | 0.8 | -19.4% |
| YTD | 6 669 804 | 13.4% | 5.9% | 0.2 | 1 317 707 124 | 33.8% | 5.6% | 0.5 | 9.3% |
| MAT | 14 055 190 | 35.9% | 6.5% | 1.3 | 2 623 747 860 | 59.2% | 6.0% | 1.4 | 8.7% |
| DEXALGIN | |||||||||
| WoW | 17 128 | -1.5% | 0.4% | 0 | 7 949 492 | -1.2% | 1.1% | -0.1 | 10.3% |
| MoM | 117 256 | -6.4% | 0.7% | 0 | 50 089 782 | -6.6% | 1.9% | 0 | -4.1% |
| YTD | 1 206 777 | 20.6% | 0.8% | 0.1 | 502 337 179 | 32.2% | 2.0% | 0.3 | 4.6% |
| MAT | 2 045 236 | 9.4% | 0.8% | 0 | 823 433 128 | 18.2% | 2.1% | 0.1 | 2.8% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 57 543 | 2.9% | 47.0% | 0 | 30 482 616 | 3.9% | 52.9% | 0.3 | 2.8% |
| MoM | 318 430 | -5.2% | 55.8% | -1 | 161 646 972 | -6.1% | 61.2% | -1.4 | -3.6% |
| YTD | 3 133 040 | 1.7% | 57.9% | -8.7 | 1 583 021 964 | 14.4% | 63.3% | -6.9 | 17.0% |
| MAT | 5 334 178 | 6.2% | 60.6% | -5.5 | 2 623 726 382 | 20.3% | 66.1% | -4 | 15.8% |
| ESPUMISAN BABY | |||||||||
| WoW | 22 975 | 3.9% | 35.0% | 1 | 14 801 049 | 5.8% | 48.0% | 1.6 | 0.9% |
| MoM | 100 138 | -6.9% | 37.7% | -1.4 | 63 444 221 | -5.9% | 50.6% | -1.3 | -3.4% |
| YTD | 948 358 | -7.3% | 38.7% | -3.2 | 585 763 489 | -1.1% | 52.1% | -4.8 | 0.4% |
| MAT | 1 588 195 | -8.8% | 39.4% | -1.9 | 965 049 092 | -0.5% | 53.2% | -2 | -4.5% |
| FASTUM | |||||||||
| WoW | 14 032 | -4.5% | 0.9% | -0.1 | 7 650 735 | -5.1% | 2.0% | -0.1 | 1.6% |
| MoM | 71 372 | -12.0% | 1.1% | 0 | 37 717 439 | -10.8% | 2.4% | 0 | -14.1% |
| YTD | 721 289 | -15.4% | 1.2% | -0.3 | 367 516 704 | -6.2% | 2.6% | -0.5 | 2.2% |
| MAT | 1 253 549 | -14.1% | 1.3% | -0.2 | 615 730 145 | -5.9% | 2.8% | -0.4 | 1.1% |
| IODOMARIN | |||||||||
| WoW | 53 753 | 1.3% | 20.9% | -0.9 | 10 327 855 | -0.0% | 9.4% | -0.2 | 5.7% |
| MoM | 215 761 | -8.7% | 21.2% | 0.4 | 43 032 457 | -12.6% | 9.6% | -0.2 | -10.6% |
| YTD | 1 853 088 | 6.1% | 18.8% | -0.2 | 373 143 234 | 13.4% | 8.5% | 0 | 7.0% |
| MAT | 3 273 027 | 21.9% | 20.4% | 2.5 | 636 635 277 | 23.4% | 9.3% | 0.9 | 7.2% |
| LIOTON | |||||||||
| WoW | 20 698 | -0.3% | 2.0% | -0.1 | 22 102 456 | 0.5% | 4.1% | -0.2 | 4.4% |
| MoM | 101 978 | -9.4% | 2.4% | 0 | 105 289 953 | -11.3% | 4.7% | 0 | -9.5% |
| YTD | 907 502 | -17.9% | 2.5% | -0.4 | 921 019 207 | 3.4% | 4.9% | -0.7 | -5.5% |
| MAT | 1 494 329 | -14.2% | 2.5% | -0.2 | 1 433 144 732 | 4.8% | 5.1% | -0.4 | -5.7% |
| MEZYM | |||||||||
| WoW | 214 878 | 8.3% | 20.0% | 0.7 | 32 582 572 | 7.8% | 14.3% | 0.9 | 4.7% |
| MoM | 1 268 153 | -0.1% | 27.4% | 1 | 195 815 455 | 1.4% | 19.8% | 1.3 | -3.9% |
| YTD | 12 883 132 | 17.2% | 28.9% | 2.6 | 1 972 044 701 | 26.7% | 20.7% | 0.9 | 6.8% |
| MAT | 22 653 190 | 22.6% | 30.5% | 3.5 | 3 324 469 073 | 28.5% | 22.1% | 1.6 | 8.4% |
| MIG 400 | |||||||||
| WoW | 137 681 | 8.9% | 3.0% | 0 | 16 433 654 | 9.3% | 2.2% | 0 | 10.3% |
| MoM | 595 570 | -7.5% | 3.6% | -0.1 | 69 690 474 | -8.5% | 2.6% | -0.1 | -4.1% |
| YTD | 5 539 035 | -2.0% | 3.5% | -0.2 | 649 797 792 | 1.4% | 2.6% | -0.4 | 4.6% |
| MAT | 9 778 887 | 6.7% | 3.6% | 0.1 | 1 125 844 365 | 9.8% | 2.8% | 0 | 2.8% |
| PROSTAMOL | |||||||||
| WoW | 19 172 | 7.6% | 15.6% | 0.9 | 26 774 546 | 6.6% | 16.3% | 0.6 | 1.5% |
| MoM | 93 730 | -9.6% | 17.9% | -0.4 | 129 382 622 | -10.4% | 18.8% | -0.8 | -7.6% |
| YTD | 1 079 858 | -15.4% | 20.3% | -4.5 | 1 515 813 365 | -4.9% | 21.7% | -5.5 | 3.3% |
| MAT | 1 943 630 | -7.8% | 21.9% | -2.6 | 2 621 918 161 | 0.7% | 23.3% | -3.5 | 3.0% |
| RESPERO MYRTOL | |||||||||
| WoW | 13 800 | 7.6% | 9.1% | -0.3 | 6 502 028 | 8.6% | 9.2% | -0.2 | 11.0% |
| MoM | 44 155 | -22.5% | 7.9% | 0.4 | 20 644 482 | -23.6% | 7.8% | 0.5 | -26.4% |
| YTD | 779 856 | 188.2% | 9.1% | 5.6 | 363 260 954 | 179.3% | 8.8% | 4.9 | 9.2% |
| MAT | 1 256 096 | 119.1% | 8.2% | 4 | 578 090 925 | 108.0% | 8.0% | 3.3 | 11.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 6 669 804 | 13.4% | 5.9% | 0.2 | 1 317 707 124 | 33.8% | 5.6% | 0.5 | 9.3% |
| DEXALGIN | 1 206 777 | 20.6% | 0.8% | 0.1 | 502 337 179 | 32.2% | 2.0% | 0.3 | 4.6% |
| ESPUMISAN (ADULTS) | 3 133 040 | 1.7% | 57.9% | -8.7 | 1 583 021 964 | 14.4% | 63.3% | -6.9 | 17.0% |
| ESPUMISAN BABY | 948 358 | -7.3% | 38.7% | -3.2 | 585 763 489 | -1.1% | 52.1% | -4.8 | 0.4% |
| FASTUM | 721 289 | -15.4% | 1.2% | -0.3 | 367 516 704 | -6.2% | 2.6% | -0.5 | 2.2% |
| IODOMARIN | 1 853 088 | 6.1% | 18.8% | -0.2 | 373 143 234 | 13.4% | 8.5% | 0 | 7.0% |
| LIOTON | 907 502 | -17.9% | 2.5% | -0.4 | 921 019 207 | 3.4% | 4.9% | -0.7 | -5.5% |
| MEZYM | 12 883 132 | 17.2% | 28.9% | 2.6 | 1 972 044 701 | 26.7% | 20.7% | 0.9 | 6.8% |
| MIG 400 | 5 539 035 | -2.0% | 3.5% | -0.2 | 649 797 792 | 1.4% | 2.6% | -0.4 | 4.6% |
| PROSTAMOL | 1 079 858 | -15.4% | 20.3% | -4.5 | 1 515 813 365 | -4.9% | 21.7% | -5.5 | 3.3% |
| RESPERO MYRTOL | 779 856 | 188.2% | 9.1% | 5.6 | 363 260 954 | 179.3% | 8.8% | 4.9 | 9.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 14 055 190 | 35.9% | 6.5% | 1.3 | 2 623 747 860 | 59.2% | 6.0% | 1.4 | 8.7% |
| DEXALGIN | 2 045 236 | 9.4% | 0.8% | 0 | 823 433 128 | 18.2% | 2.1% | 0.1 | 2.8% |
| ESPUMISAN (ADULTS) | 5 334 178 | 6.2% | 60.6% | -5.5 | 2 623 726 382 | 20.3% | 66.1% | -4 | 15.8% |
| ESPUMISAN BABY | 1 588 195 | -8.8% | 39.4% | -1.9 | 965 049 092 | -0.5% | 53.2% | -2 | -4.5% |
| FASTUM | 1 253 549 | -14.1% | 1.3% | -0.2 | 615 730 145 | -5.9% | 2.8% | -0.4 | 1.1% |
| IODOMARIN | 3 273 027 | 21.9% | 20.4% | 2.5 | 636 635 277 | 23.4% | 9.3% | 0.9 | 7.2% |
| LIOTON | 1 494 329 | -14.2% | 2.5% | -0.2 | 1 433 144 732 | 4.8% | 5.1% | -0.4 | -5.7% |
| MEZYM | 22 653 190 | 22.6% | 30.5% | 3.5 | 3 324 469 073 | 28.5% | 22.1% | 1.6 | 8.4% |
| MIG 400 | 9 778 887 | 6.7% | 3.6% | 0.1 | 1 125 844 365 | 9.8% | 2.8% | 0 | 2.8% |
| PROSTAMOL | 1 943 630 | -7.8% | 21.9% | -2.6 | 2 621 918 161 | 0.7% | 23.3% | -3.5 | 3.0% |
| RESPERO MYRTOL | 1 256 096 | 119.1% | 8.2% | 4 | 578 090 925 | 108.0% | 8.0% | 3.3 | 11.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 87 210 | 19.2% | 3.8% | 0.2 | 17 314 040 | 18.5% | 3.7% | 0.2 | 14.2% |
| DEXALGIN | 17 128 | -1.5% | 0.4% | 0 | 7 949 492 | -1.2% | 1.1% | -0.1 | 10.3% |
| ESPUMISAN (ADULTS) | 57 543 | 2.9% | 47.0% | 0 | 30 482 616 | 3.9% | 52.9% | 0.3 | 2.8% |
| ESPUMISAN BABY | 22 975 | 3.9% | 35.0% | 1 | 14 801 049 | 5.8% | 48.0% | 1.6 | 0.9% |
| FASTUM | 14 032 | -4.5% | 0.9% | -0.1 | 7 650 735 | -5.1% | 2.0% | -0.1 | 1.6% |
| IODOMARIN | 53 753 | 1.3% | 20.9% | -0.9 | 10 327 855 | -0.0% | 9.4% | -0.2 | 5.7% |
| LIOTON | 20 698 | -0.3% | 2.0% | -0.1 | 22 102 456 | 0.5% | 4.1% | -0.2 | 4.4% |
| MEZYM | 214 878 | 8.3% | 20.0% | 0.7 | 32 582 572 | 7.8% | 14.3% | 0.9 | 4.7% |
| MIG 400 | 137 681 | 8.9% | 3.0% | 0 | 16 433 654 | 9.3% | 2.2% | 0 | 10.3% |
| PROSTAMOL | 19 172 | 7.6% | 15.6% | 0.9 | 26 774 546 | 6.6% | 16.3% | 0.6 | 1.5% |
| RESPERO MYRTOL | 13 800 | 7.6% | 9.1% | -0.3 | 6 502 028 | 8.6% | 9.2% | -0.2 | 11.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 467 964 | -5.9% | 6.2% | 0.9 | 91 081 370 | -7.9% | 5.7% | 0.8 | -19.4% |
| DEXALGIN | 117 256 | -6.4% | 0.7% | 0 | 50 089 782 | -6.6% | 1.9% | 0 | -4.1% |
| ESPUMISAN (ADULTS) | 318 430 | -5.2% | 55.8% | -1 | 161 646 972 | -6.1% | 61.2% | -1.4 | -3.6% |
| ESPUMISAN BABY | 100 138 | -6.9% | 37.7% | -1.4 | 63 444 221 | -5.9% | 50.6% | -1.3 | -3.4% |
| FASTUM | 71 372 | -12.0% | 1.1% | 0 | 37 717 439 | -10.8% | 2.4% | 0 | -14.1% |
| IODOMARIN | 215 761 | -8.7% | 21.2% | 0.4 | 43 032 457 | -12.6% | 9.6% | -0.2 | -10.6% |
| LIOTON | 101 978 | -9.4% | 2.4% | 0 | 105 289 953 | -11.3% | 4.7% | 0 | -9.5% |
| MEZYM | 1 268 153 | -0.1% | 27.4% | 1 | 195 815 455 | 1.4% | 19.8% | 1.3 | -3.9% |
| MIG 400 | 595 570 | -7.5% | 3.6% | -0.1 | 69 690 474 | -8.5% | 2.6% | -0.1 | -4.1% |
| PROSTAMOL | 93 730 | -9.6% | 17.9% | -0.4 | 129 382 622 | -10.4% | 18.8% | -0.8 | -7.6% |
| RESPERO MYRTOL | 44 155 | -22.5% | 7.9% | 0.4 | 20 644 482 | -23.6% | 7.8% | 0.5 | -26.4% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"
## [1] "MIG 400"
## [1] "MIG 400 COATED TABLETS 400 MG #10"
## [1] "MIG 400 COATED TABLETS 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs